Michel Baudry

Company: NeurAegis

Job title: Chief Scientific Officer

Seminars:

Roundtable Discussion: Tailoring Formulation Strategy for Large & Small Molecule APIs 3:00 pm

Exploring factors such as nasal metabolism, hepatic metabolism and pH levels to avoid nasal mucosal toxicity, and smolality to enhance bioavailability Utilizing the protective aspect of the nasal cavity against external bio products while exploring sustained-release nano formulations Evaluating the impact of device choice in small vs. large molecules and incorporating viscosifying agents for improved…Read more

day: Conference Day One

Enhancing & Accurately Validating Delivery to the Brain for a Novel Nasal Anti-Epileptic Formulation 12:00 pm

Formulation approaches and device considerations for early stage development of a novel anti-epileptic Developing a robust analytical strategy to produce promising, translatable results from mouse models Employing blood biomarkers to precisely trace drug migration to the target areas of the brainRead more

day: Conference Day One